{"entity":{"type":"insider","cik":"0001564955","url":"/insider/0001564955","json_url":"/insider/0001564955.json","name":"Madison Greg","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":26,"first":"2015-02-10","last":"2018-02-16","span_basis":"filed_date"},"name_variants":[{"name":"Madison Greg","source":"filing","n_filings":26,"first_seen":"2015-02-10","last_seen":"2018-02-16"}],"transactions":[{"id":6184289,"accession":"0001114220-18-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000023","line_url":"/filing/0001114220-18-000023#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15318.0,"shares_display":"15,318","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":73679.58,"total_display":"73,679.58","total_whole":"73,680","shares_owned_after":414086.0,"shares_owned_after_display":"414,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-16","scope":"insider"},{"id":6541336,"accession":"0001114220-18-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000003","line_url":"/filing/0001114220-18-000003#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1067.0,"shares_display":"1,067","price_per_share":4.69,"price_display":"4.69","price_state":"stated","total_value":5004.23,"total_display":"5,004.23","total_whole":"5,004","shares_owned_after":367620.0,"shares_owned_after_display":"367,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-05","filed_date":"2018-01-08","scope":"insider"},{"id":4697102,"accession":"0001114220-17-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000040","line_url":"/filing/0001114220-17-000040#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4055.0,"shares_display":"4,055","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":24451.65,"total_display":"24,451.65","total_whole":"24,452","shares_owned_after":368687.0,"shares_owned_after_display":"368,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-30","filed_date":"2017-10-31","scope":"insider"},{"id":4112204,"accession":"0001114220-17-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000031","line_url":"/filing/0001114220-17-000031#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":895.0,"shares_display":"895","price_per_share":7.19,"price_display":"7.19","price_state":"stated","total_value":6435.05,"total_display":"6,435.05","total_whole":"6,435","shares_owned_after":372742.0,"shares_owned_after_display":"372,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-05","filed_date":"2017-10-06","scope":"insider"},{"id":5211658,"accession":"0001114220-17-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-17-000026","line_url":"/filing/0001114220-17-000026#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4131.0,"shares_display":"4,131","price_per_share":7.14,"price_display":"7.14","price_state":"stated","total_value":29495.34,"total_display":"29,495.34","total_whole":"29,495","shares_owned_after":373637.0,"shares_owned_after_display":"373,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-01","scope":"insider"},{"id":4439186,"accession":"0000899243-17-018006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-018006","line_url":"/filing/0000899243-17-018006#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":910.0,"shares_display":"910","price_per_share":7.67,"price_display":"7.67","price_state":"stated","total_value":6979.7,"total_display":"6,979.70","total_whole":"6,980","shares_owned_after":377768.0,"shares_owned_after_display":"377,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-06","scope":"insider"},{"id":4690835,"accession":"0000899243-17-011614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-011614","line_url":"/filing/0000899243-17-011614#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4122.0,"shares_display":"4,122","price_per_share":5.97,"price_display":"5.97","price_state":"stated","total_value":24608.34,"total_display":"24,608.34","total_whole":"24,608","shares_owned_after":378678.0,"shares_owned_after_display":"378,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-03","scope":"insider"},{"id":5151904,"accession":"0000899243-17-009649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-009649","line_url":"/filing/0000899243-17-009649#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":5.8,"price_display":"5.80","price_state":"stated","total_value":5283.8,"total_display":"5,283.80","total_whole":"5,284","shares_owned_after":382800.0,"shares_owned_after_display":"382,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-05","filed_date":"2017-04-06","scope":"insider"},{"id":5050559,"accession":"0000899243-17-003790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-003790","line_url":"/filing/0000899243-17-003790#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1611.0,"shares_display":"1,611","price_per_share":5.47,"price_display":"5.47","price_state":"stated","total_value":8812.17,"total_display":"8,812.17","total_whole":"8,812","shares_owned_after":233711.0,"shares_owned_after_display":"233,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-13","scope":"insider"},{"id":4522629,"accession":"0000899243-17-002273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-002273","line_url":"/filing/0000899243-17-002273#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18248.0,"shares_display":"18,248","price_per_share":4.65,"price_display":"4.65","price_state":"stated","total_value":84853.2,"total_display":"84,853.20","total_whole":"84,853","shares_owned_after":235322.0,"shares_owned_after_display":"235,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-30","filed_date":"2017-01-31","scope":"insider"},{"id":4926649,"accession":"0000899243-17-000669","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-000669","line_url":"/filing/0000899243-17-000669#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1077.0,"shares_display":"1,077","price_per_share":6.16,"price_display":"6.16","price_state":"stated","total_value":6634.32,"total_display":"6,634.32","total_whole":"6,634","shares_owned_after":253570.0,"shares_owned_after_display":"253,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-05","filed_date":"2017-01-06","scope":"insider"},{"id":3354373,"accession":"0000899243-16-033319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-033319","line_url":"/filing/0000899243-16-033319#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1559.0,"shares_display":"1,559","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":7779.41,"total_display":"7,779.41","total_whole":"7,779","shares_owned_after":254647.0,"shares_owned_after_display":"254,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-14","scope":"insider"},{"id":2201362,"accession":"0000899243-16-031391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-031391","line_url":"/filing/0000899243-16-031391#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":917.0,"shares_display":"917","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":4933.46,"total_display":"4,933.46","total_whole":"4,933","shares_owned_after":256206.0,"shares_owned_after_display":"256,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-05","filed_date":"2016-10-06","scope":"insider"},{"id":3194865,"accession":"0000899243-16-026843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-026843","line_url":"/filing/0000899243-16-026843#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1622.0,"shares_display":"1,622","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":6844.84,"total_display":"6,844.84","total_whole":"6,845","shares_owned_after":257123.0,"shares_owned_after_display":"257,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-09","filed_date":"2016-08-11","scope":"insider"},{"id":2200863,"accession":"0000899243-16-026842","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-026842","line_url":"/filing/0000899243-16-026842#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1622.0,"shares_display":"1,622","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":6844.84,"total_display":"6,844.84","total_whole":"6,845","shares_owned_after":257123.0,"shares_owned_after_display":"257,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-09","filed_date":"2016-08-11","scope":"insider"},{"id":3069539,"accession":"0000899243-16-024586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-024586","line_url":"/filing/0000899243-16-024586#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":936.0,"shares_display":"936","price_per_share":6.66,"price_display":"6.66","price_state":"stated","total_value":6233.76,"total_display":"6,233.76","total_whole":"6,234","shares_owned_after":258745.0,"shares_owned_after_display":"258,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-06","scope":"insider"},{"id":2267748,"accession":"0000899243-16-019583","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-019583","line_url":"/filing/0000899243-16-019583#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1873.0,"shares_display":"1,873","price_per_share":5.42,"price_display":"5.42","price_state":"stated","total_value":10151.66,"total_display":"10,151.66","total_whole":"10,152","shares_owned_after":259681.0,"shares_owned_after_display":"259,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-09","filed_date":"2016-05-10","scope":"insider"},{"id":2349389,"accession":"0000899243-16-017770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-017770","line_url":"/filing/0000899243-16-017770#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1078.0,"shares_display":"1,078","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":4851.0,"total_display":"4,851.00","total_whole":"4,851","shares_owned_after":261554.0,"shares_owned_after_display":"261,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-05","filed_date":"2016-04-07","scope":"insider"},{"id":2267476,"accession":"0000899243-16-013036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-013036","line_url":"/filing/0000899243-16-013036#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1938.0,"shares_display":"1,938","price_per_share":3.23,"price_display":"3.23","price_state":"stated","total_value":6259.74,"total_display":"6,259.74","total_whole":"6,260","shares_owned_after":262632.0,"shares_owned_after_display":"262,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-09","filed_date":"2016-02-10","scope":"insider"},{"id":2936638,"accession":"0000899243-16-011229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-011229","line_url":"/filing/0000899243-16-011229#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4261.0,"shares_display":"4,261","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":20580.63,"total_display":"20,580.63","total_whole":"20,581","shares_owned_after":110820.0,"shares_owned_after_display":"110,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-06","filed_date":"2016-01-06","scope":"insider"},{"id":8856009,"accession":"0000899243-15-008065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-008065","line_url":"/filing/0000899243-15-008065#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1638.0,"shares_display":"1,638","price_per_share":5.18,"price_display":"5.18","price_state":"stated","total_value":8484.84,"total_display":"8,484.84","total_whole":"8,485","shares_owned_after":115081.0,"shares_owned_after_display":"115,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-09","filed_date":"2015-11-12","scope":"insider"},{"id":8196515,"accession":"0000899243-15-003911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-003911","line_url":"/filing/0000899243-15-003911#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9984.0,"shares_display":"9,984","price_per_share":5.685,"price_display":"5.68","price_state":"stated","total_value":56759.04,"total_display":"56,759.04","total_whole":"56,759","shares_owned_after":116719.0,"shares_owned_after_display":"116,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-24","scope":"insider"},{"id":8391498,"accession":"0000899243-15-002994","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-002994","line_url":"/filing/0000899243-15-002994#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1683.0,"shares_display":"1,683","price_per_share":6.07,"price_display":"6.07","price_state":"stated","total_value":10215.81,"total_display":"10,215.81","total_whole":"10,216","shares_owned_after":106735.0,"shares_owned_after_display":"106,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-10","filed_date":"2015-08-12","scope":"insider"},{"id":9269518,"accession":"0001209191-15-024956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-024956","line_url":"/filing/0001209191-15-024956#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6380.0,"shares_display":"6,380","price_per_share":12.53,"price_display":"12.53","price_state":"stated","total_value":79941.4,"total_display":"79,941.40","total_whole":"79,941","shares_owned_after":110043.0,"shares_owned_after_display":"110,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-06","filed_date":"2015-03-11","scope":"insider"},{"id":8783628,"accession":"0001209191-15-024755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-024755","line_url":"/filing/0001209191-15-024755#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6380.0,"shares_display":"6,380","price_per_share":12.53,"price_display":"12.53","price_state":"stated","total_value":79941.4,"total_display":"79,941.40","total_whole":"79,941","shares_owned_after":110043.0,"shares_owned_after_display":"110,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-06","filed_date":"2015-03-10","scope":"insider"},{"id":8210907,"accession":"0001209191-15-011723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-011723","line_url":"/filing/0001209191-15-011723#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001564955","owner_name":"Madison Greg","owner_display_name":"Madison Greg","owner_url":"/insider/0001564955","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6759.0,"shares_display":"6,759","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":74011.05,"total_display":"74,011.05","total_whole":"74,011","shares_owned_after":103663.0,"shares_owned_after_display":"103,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001114220","name":"KERYX BIOPHARMACEUTICALS INC","url":"/issuer/0001114220","role":"Director, Officer (President and CEO)","n_filings":26,"first_seen":"2015-02-10","last_seen":"2018-02-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001564955","retrieved_at":"2026-08-26T17:26:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}